The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in chronic ...

Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, ...

Researchers conducted a cross-sectional study to examine hepatitis B treatment trends among adults in the United States.

By focusing on chromatin-modifying enzymes, viral proteins, and noncoding RNAs, the researchers hope to uncover new pathways for a functional cure for chronic hepatitis B. The review highlights the ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even after treatment. But, thanks to a new class of drugs, its luck ...

Liver specialist Maurizio Bonacini is in the race for a cure for hepatitis B, one of the world’s most widespread diseases and a top cause of liver cancer around the globe. “It’s the last frontier,” ...

Bepirovirsen demonstrated a statistically significant functional cure rate vs placebo in participants with baseline HBsAg less than or equal to 3000 IU/mL. Topline data were announced from two phase 3 ...

(Yicai) Jan. 21 -- Chinese innovative pharmaceutical company Kawin Technology plummeted today after withdrawing its ...

A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face substantially higher risks of kidney dysfunction than those living with HIV ...

The Hepatitis B Co-care Scheme, allowing eligible individuals to receive a hepatitis B risk assessment, screening and ...